Director / PDMR Shareholding

 1st Oct 2014

EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care, central laboratory and molecular diagnostics business, was informed on 1 October 2014 that David Evans, Executive Chairman, purchased shares in the Company on 1 October 2014.

David purchased 100,000 ordinary shares of 1 pence each in EKF at a purchase price of 23 pence per share.

David’s total shareholding following this purchase is 1,805,753 ordinary shares, which represents 0.43% of the Company’s issued share capital.